095720.KS - Woongjin Thinkbig Co., Ltd.

KSE - KSE Delayed Price. Currency in KRW
-15.00 (-0.49%)
At close: 03:30PM KST
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
Previous Close3,040.00
Bid3,020.00 x N/A
Ask3,015.00 x N/A
Day's Range2,990.00 - 3,065.00
52 Week Range2,125.00 - 3,580.00
Avg. Volume952,192
Market Cap340.866B
Beta (5Y Monthly)0.99
PE Ratio (TTM)N/A
Earnings DateAug 07, 2023 - Aug 11, 2023
Forward Dividend & Yield140.00 (4.61%)
Ex-Dividend DateDec 28, 2022
1y Target Est4,250.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for 095720.KS

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • GlobeNewswire

      Enzo Biochem to Report Third Quarter 2022 Financial Results and Business Update on Thursday, June 9th

      Conference Call and Webcast Scheduled for June 9, 2022, 4:30 pm ET NEW YORK, NY, June 02, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, announced today that it will report third quarter 2022 financial results on Thursday, June 9, 2022, after the market close. The announcement will be followed by a live audio webcast and conference call at 4:30 pm Eastern Time. Thursday, June 9th @ 4:30 pm ETDomestic: 877-407-0792International: 201-689-8263